Cell Source, Inc. announced that onJuly 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | +300.00% | -.--% | -99.83% |
Jun. 24 | Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 22 | Cell Source, Inc. announced that it has received $4.76017 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-99.83% | 32.82K | |
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- CLCS Stock
- News Cell Source, Inc.
- Cell Source, Inc. Announces Board Resignations